Getinge presents lifesaving medtech innovations at APELSO 2023
Getinge announces its commitment to APELSO 2023, set to take place in Seoul from November 2-4. Attendees will get an exclusive look at innovations from the medtech company’s acute care therapies portfolio, spotlighting advanced solutions for Extracorporeal Membrane Oxygenation (ECMO) and cardiovascular procedures.
In the quest to save lives and mitigate long-term complications, the integration of innovative, sustainable solutions and cutting-edge technologies is vital. Getinge is at the forefront of offering world-class products for life support and therapies, addressing acute health conditions – solutions that are contributing to saving 10 million lives every year.
“We are committed to collaborating with healthcare professionals to unveil advanced clinical solutions and boost knowledge. Our innovations are tailored to optimize therapy results, improve patient recovery, and enhance the quality of life for those in intensive care and surgery,” says Philippe Rocher, President South Asia Pacific at Getinge.
APELSO 2023, coinciding with the 55th Annual Meeting of the Korean Society of Thoracic and Cardiovascular Surgery, will witness Getinge’s acute care therapies solutions with focus on Extracorporeal Membrane Oxygenation (ECMO), and cardiovascular procedures and Neurally Adjusted Ventilatory Assist (NAVA). Live demonstrations and expert interviews at booths 6-9 will underscore the crucial role and evolution of ECMO and the essentials of specialized training in this domain.
APELSO 2023 is anticipated to host approximately 1,500 participants, offering a platform for knowledge exchange, networking, and insights to the latest trends and innovations in extracorporeal life support.
Registered delegates are invited to experience Getinge’s transformative solutions firsthand at booths 6-9 from November 2-4, 2023.